<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05061290</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-2019-764</org_study_id>
    <nct_id>NCT05061290</nct_id>
  </id_info>
  <brief_title>Iron Bioavailability From Cereal-based Foods</brief_title>
  <official_title>The Potential of Food to Food Fortification to Improve Iron Bioavailability From Cereal-based Foods</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Purdue University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Purdue University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Iron-deficient anemia is a chronic problem in sub-Saharan Africa and other developing areas&#xD;
      of the world. From our previous research, we have shown that certain local plant foods in&#xD;
      Kenya and Senegal have an unusual action of improving in vitro iron bioaccessibility (nearly&#xD;
      doubling the low value obtained in cereals). We will assess absorption of stable isotopes of&#xD;
      iron (57Fe, 54Fe and 58Fe) extrinsically labeled in a serving of porridge fortified with&#xD;
      various combinations of moringa, baobab, mango, carrot and standard fortificant iron sulfate&#xD;
      and the enhancer ascorbic acid.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To better understand the potential for leveraging traditional plant-based ingredients in&#xD;
      local fortification efforts in Africa, the proposed study will focus on assessment of acute&#xD;
      iron bioavailability in participants consuming instant blended cereal porridges produced&#xD;
      using whole grain white maize, with provitamin A (e.g. carrots/mango), moringa leaf powder&#xD;
      and baobab fruit powder in specific combinations. We hypothesize that: food-to-food fortified&#xD;
      cereal-based porridge with with African baobab fruit and moringa leaf powder will effectively&#xD;
      improve iron density and bioavailability in human participants as compared to a &quot;gold&#xD;
      standard&quot; fortification (iron sulphate and ascorbic acid).&#xD;
&#xD;
      A randomized crossover design with 4 different white maize cereal-based porridges and a&#xD;
      reference control porridge (with matching macronutrient contents) will be used, allowing each&#xD;
      participant to serve as their own control. Porridges are designed to specifically compare:&#xD;
      (1) Food to food fortification versus standard fortifications and (2) the ability of baobab&#xD;
      fruit pulp to enhance iron absorption from both natural and standard sources. The porridges&#xD;
      will be composed of locally sourced ingredients including: whole grain white maize, a&#xD;
      pro-vitamin A source (oil and available vegetables e.g. carrot and mango) baobab fruit powder&#xD;
      and moringa leaf powder.&#xD;
&#xD;
      The enrolled participants will come into the clinic 6 times to consume porridges or have&#xD;
      blood drawn. Four times blood (1 for screening, 3 for study) will be drawn to determine the&#xD;
      amount of the different forms of iron in participant's blood. On each day of porridge&#xD;
      consumption (each visit except the final visit on Day 33), they will consume 2 x 350 g&#xD;
      porridge meals and stay 90 mins after the participant has finished each of the meals, and&#xD;
      then leave and come back to repeat for a total of 4 hours. After two weeks they will return&#xD;
      to the clinic and we will ask to draw some more blood to see if they have absorbed any of the&#xD;
      different forms of iron. They will then have the next porridge. Importantly for each visit&#xD;
      for both blood draws and the porridge consumption the participants will have to fast the&#xD;
      previous night, so no food or beverages like tea or coffee can be consumed (only water&#xD;
      allowed). During 5 visits when they will eat two portions of porridge during the day and will&#xD;
      have to stay at the facility for 90 mins after each porridge consumption. During the last&#xD;
      visit (Day 33), participants will need to give a blood sample, which will take about half an&#xD;
      hour. Blood collected during these visits will be used to measure isotopic iron absorbed from&#xD;
      the porridges.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Iron absorption</measure>
    <time_frame>Acute study but blood measurement to occur following 14 daysof acute consumption</time_frame>
    <description>Assessment whole blood for isotopic iron absorption from individual meals</description>
  </primary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Iron Bioavailability</condition>
  <arm_group>
    <arm_group_label>Control Porridge</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wholegrain maize flour, Mango powder, Carrot powder, Ferrous sulfate, Corn starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reference Porride A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wholegrain maize flour, Mango powder, Carrot powder, Ferrous sulfate, Ascorbic acid, Corn starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Porridge B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wholegrain maize flour, Moringa leaf powder, Mango powder, Carrot powder, Corn starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Porridge C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wholegrain maize flour, Baobab fruit powder, Mango powder, Carrot powder, Ferrous sulfate, Corn starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Porridge D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wholegrain maize flour, Baobab fruit powder, Moringa leaf powder, Mango powder, Carrot powder</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Porridge</intervention_name>
    <description>Maize porridge containing 54Fe as iron sulfate</description>
    <arm_group_label>Control Porridge</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Reference Porridge A</intervention_name>
    <description>Maize porridge counting 58Fe as iron sulfate with ascorbic acid</description>
    <arm_group_label>Reference Porride A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test Porridge B</intervention_name>
    <description>Maize porridge containing 57Fe and fortified with Moringa leaf powder as iron source</description>
    <arm_group_label>Test Porridge B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test Porridge C</intervention_name>
    <description>Maize porridge containing 57Fe and fortified with Boabab fruit powder as iron source</description>
    <arm_group_label>Test Porridge C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Test Porridge D</intervention_name>
    <description>Maize porridge containing 54Fe and fortified with Moringa leaf and Baobab fruit powder as iron source</description>
    <arm_group_label>Test Porridge D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion:&#xD;
&#xD;
        Female 18-65 Y BMI 18.5-25 kg/m2 Stable weight past 3 month (+/- 2.5kg) Clinically normal&#xD;
        blood profiles Fasting blood glucose &lt; 110 and CRP below 3 mg/L&#xD;
&#xD;
        Exclusion:&#xD;
&#xD;
        Smokers and vapers No heavy alcohol consumption (&gt;2 drinks per day) Diabetic Presence of&#xD;
        metabolic of intestinal disorder including lipid malabsorption or lactose intolerance Male&#xD;
        sex Pregnant Lactating Long term use of medications Blood donation in past 4 months&#xD;
        Previous participation in iron stable isotope bioavailability study Following a weight&#xD;
        reduction program or having one in past 3 months Peri- or post-menopausal Acute or chronic&#xD;
        disease Hypertension&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruce Hamaker</last_name>
    <phone>7654945668</phone>
    <email>hamakerb@purdue.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Purdue University</name>
      <address>
        <city>West Lafayette</city>
        <state>Indiana</state>
        <zip>47907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce R Hamaker, PhD</last_name>
      <phone>765-494-5668</phone>
      <email>hamakerb@purdue.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Purdue University</investigator_affiliation>
    <investigator_full_name>Bruce R. Hamaker</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be shared with other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

